GlassScriptPhysician profile
Charles G Anderson
NPI 1720197635
$1,160.36
in general payments reported to CMS, 2019-2025
18 companies · $43.08 in 2025
The $43.08 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $251 · 2021: $219 · 2022: $266 · 2023: $188 · 2024: $53.68 · 2025: $43.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $499.10 | 2019-2025 | Liletta, Qulipta, Ubrelvy |
| Acessa Health INC. | $138.58 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $75.29 | 2023 | |
| Minerva Surgical, INC | $59.17 | 2019 | |
| Pfizer INC. | $45.78 | 2019-2021 | |
| Therapeuticsmd, INC. | $43.78 | 2020-2021 | |
| Allergan, INC. | $37.12 | 2020 | |
| Lupin INC. | $34.30 | 2019 | |
| Exeltis, USA INC. | $34.04 | 2022-2023 | Slynd |
| Astellas Pharma US INC | $32.86 | 2023-2024 | Veozah |
| Eisai INC. | $32.11 | 2020 | |
| Lilly USA, LLC | $29.67 | 2020 | |
| Organon LLC | $23.81 | 2022 | |
| Merck Sharp & Dohme LLC | $20.92 | 2020 | |
| Biogen, INC. | $19.33 | 2025 | Zurzuvae |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $17.42 | 2022 | |
| Evofem Biosciences, INC. | $17.08 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.